(Q36961175)

17 August 2017

1 reference

title

TWEAK and the central nervous system (English)

1 reference

17 August 2017

Manuel Yepes

1

1 reference

PubMed ID

17917114

17 August 2017

language of work or name

1 reference

1 June 2007

1 reference

17 August 2017

Molecular Neurobiology

1 reference

17 August 2017

35

1 reference

17 August 2017

3

1 reference

17 August 2017

255-265

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-007-0024-z

17 August 2017

0 references

cites work

Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0024-Z

The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0024-Z

Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0024-Z

A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0024-Z

The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0024-Z

Multiple pathways of TWEAK-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0024-Z

Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0024-Z

Stroke Incidence, Case Fatality, and Mortality in the WHO MONICA Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0024-Z

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

21 January 2018

1 reference

12 December 2020

Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury.

1 reference

12 December 2020

An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein

1 reference

12 December 2020

Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets

1 reference

12 December 2020

The cerebral ischemic penumbra.

1 reference

12 December 2020

Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes

1 reference

12 December 2020

TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules

1 reference

12 December 2020

Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis

1 reference

12 December 2020

TWE-PRIL; a fusion protein of TWEAK and APRIL

1 reference

12 December 2020

Development of the blood-brain barrier

1 reference

12 December 2020

TWEAK induces liver progenitor cell proliferation

1 reference

12 December 2020

Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B

1 reference

12 December 2020

Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer

1 reference

12 December 2020

A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.

1 reference

12 December 2020

The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity

1 reference

12 December 2020

TWEAK attenuates the transition from innate to adaptive immunity

1 reference

12 December 2020

TWEAK shall inherit the earth

1 reference

12 December 2020

Recombinant adenoviral expression of dominant negative IkappaBalpha protects brain from cerebral ischemic injury.

1 reference

12 December 2020

1 reference

12 December 2020

The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression

1 reference

12 December 2020

Focal cerebral ischemia induces active proteases that degrade microvascular matrix

1 reference

12 December 2020

Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.

1 reference

12 December 2020

Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Proteolytic cascade enzymes increase in focal cerebral ischemia in rat

1 reference

12 December 2020

NF-kappaB is activated and promotes cell death in focal cerebral ischemia.

1 reference

12 December 2020

Tweak induces mammary epithelial branching morphogenesis.

1 reference

12 December 2020

TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.

1 reference

12 December 2020

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis-Induced Neurodegeneration

1 reference

12 December 2020

The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration

1 reference

12 December 2020

Matrix metalloproteinases in neuroinflammation

1 reference

12 December 2020

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

12 December 2020

TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages

1 reference

12 December 2020

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

12 December 2020

TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor

1 reference

12 December 2020

Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

1 reference

12 December 2020

Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.

1 reference

12 December 2020

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis

1 reference

12 December 2020

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

1 reference

12 December 2020

TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.

1 reference

12 December 2020

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

1 reference

12 December 2020

Tumor necrosis factor identified in multiple sclerosis brain

1 reference

12 December 2020

Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity

1 reference

12 December 2020

The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation

1 reference

12 December 2020

Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis

1 reference

12 December 2020

Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies

1 reference

12 December 2020

Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis

1 reference

12 December 2020

Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes

1 reference

12 December 2020

Clinical definition for multiple sclerosis treatment trials

1 reference

12 December 2020

1 reference

12 December 2020

TWEAK stimulation of astrocytes and the proinflammatory consequences

1 reference

12 December 2020

Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling

1 reference

12 December 2020

Multiple roles for MMPs and TIMPs in cerebral ischemia

1 reference

12 December 2020

Building up the blood-brain barrier.

1 reference

12 December 2020

Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases

1 reference

12 December 2020

Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth

1 reference

12 December 2020

Inflammation in atherosclerosis

1 reference

12 December 2020

Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein.

1 reference

12 December 2020

TWEAK can induce cell death via endogenous TNF and TNF receptor 1.

1 reference

12 December 2020

Nuclear factor kappaB signaling in atherogenesis.

1 reference

12 December 2020

1 reference

12 December 2020

Tumorigenesis and the angiogenic switch

1 reference

12 December 2020

TWEAK induces angiogenesis and proliferation of endothelial cells

1 reference

12 December 2020

TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor

1 reference

12 December 2020

Shaping the nuclear action of NF-kappaB

1 reference

12 December 2020

The world health report 2002 - reducing risks, promoting healthy life

1 reference

12 December 2020

Functional expression of TWEAK in human colonic adenocarcinoma cells.

1 reference

12 December 2020

Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study.

1 reference

12 December 2020

Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat.

1 reference

12 December 2020

Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation.

1 reference

12 December 2020

Dual role for TWEAK in angiogenic regulation

1 reference

12 December 2020

Angiogenesis in health and disease

1 reference

12 December 2020

Points of control in inflammation

1 reference

12 December 2020

TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity

1 reference

12 December 2020

Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

1 reference

12 December 2020

TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity

1 reference

12 December 2020

Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window

1 reference

12 December 2020

Identification of a ligand for the death-domain-containing receptor Apo3

1 reference

12 December 2020

Cerebral microvessel responses to focal ischemia

1 reference

12 December 2020

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis

1 reference

12 December 2020

Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity

1 reference

12 December 2020

Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human

1 reference

12 December 2020

Tumor necrosis factor-alpha mRNA remains unstable and hypoadenylated upon stimulation of macrophages by lipopolysaccharides

1 reference

12 December 2020

TWEAK is a novel arthritogenic mediator

1 reference

12 December 2020

Neuronal ischemic injury: Light microscopy, ultrastructure and biochemistry

1 reference

12 December 2020

TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.

1 reference

12 December 2020

10.1007/S12035-007-0024-Z

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17917114